Timothy Coskran Selected Research

Timothy Coskran Research Topics

2	Neoplasms (Cancer) 04/2024 - 12/2021
2	Atherosclerosis 05/2015 - 04/2002
1	COVID-19 01/2022
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 04/2017
1	Thrombocytopenia (Thrombopenia) 04/2017
1	Vascular System Injuries 05/2015
1	Edema (Dropsy) 05/2015
1	Glomerulonephritis 05/2015
1	Lung Diseases (Lung Disease) 05/2015
1	Thrombosis (Thrombus) 05/2015
1	Vasculitis (Vasculitides) 05/2015
1	Glucose Intolerance 07/2003
1	Hyperinsulinism (Hyperinsulinemia) 07/2003
1	Hyperglycemia 07/2003
1	Xanthomatosis (Xanthoma) 04/2002

2	Formaldehyde (Formol)FDA Link 04/2024 - 01/2022
2	ParaffinIBA 04/2024 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 04/2017
1	VaccinesIBA 01/2022
1	Gemtuzumab (Mylotarg)FDA Link 04/2017
1	CalicheamicinsIBA 04/2017
1	Inotuzumab OzogamicinIBA 04/2017
1	acetamideIBA 05/2015
1	Antigen-Antibody Complex (Immune Complex)IBA 05/2015
1	Lipoproteins (Lipoprotein)IBA 05/2015
1	Peroxidase (Myeloperoxidase)IBA 05/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2015
1	ThiouracilIBA 05/2015
1	CytokinesIBA 05/2015
1	2- (6- (2,5- dimethoxyphenyl)- 4- oxo- 2- thioxo- 3,4- dihydropyrimidin- 1(2H)- yl)acetamideIBA 05/2015
1	Protein Isoforms (Isoforms)IBA 07/2003
1	Glucose (Dextrose)FDA LinkGeneric 07/2003
1	Apolipoproteins E (ApoE)IBA 04/2002
1	Cholesterol Esters (Cholesteryl Esters)IBA 04/2002
1	CholesterolIBA 04/2002

1	Therapeutics 01/2022
1	Oral Administration 05/2015
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2002